NYMT Financial Statements & Analysis
Complete financial statements for NYMT including income statement, balance sheet, and cash flow statement. Analyze NYMT's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
-70.7% ↓
Net Income
263.0% ↑
Gross Margin
-100.0% ↓
Operating Margin
-100.0% ↓
Balance Sheet
Current Ratio
78.1% ↑
Debt to Equity
-100.0% ↑
Asset Turnover
-78.6% ↓
Cash Flow
Operating Cash Flow
852.6% ↑
Net Cash Flow
100.0% ↑
Free Cash Flow
2813.3% ↑
Cash Flow to Debt
7208692347565.4% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 509.22M | 149.30M | 70.7% | |
| Gross Profit | 37.13M | 0 | 100.0% | |
| Operating Income | 244.54M | 0 | 100.0% | |
| Net Income | -62.03M | 101.11M | 263.0% | |
| EPS | -1.14 | 1.12 | 198.2% | |
| EBITDA | 284.36M | 613.57M | 115.8% | |
| Gross Margin | 7.29% | 0.00% | 100.0% | |
| Operating Margin | 48.02% | 0.00% | 100.0% | |
| Net Income Margin | -12.18% | 67.72% | 655.9% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 149.30M | 509.22M | 210.00M | — | — |
| Gross Profit | 0 | 37.13M | 97.81M | — | — |
| Operating Income | 0 | 244.54M | 48.25M | — | — |
| Net Income | 101.11M | -62.03M | -48.66M | — | — |
| EPS | 1.12 | -1.14 | -0.99 | — | — |
| EBITDA | 613.57M | 284.36M | 206.44M | — | — |
| Gross Margin | 0.00% | 7.29% | 46.58% | — | — |
| Operating Margin | 0.00% | 48.02% | 22.98% | — | — |
| Net Income Margin | 67.72% | -12.18% | -23.17% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into NYMT's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics